Gut microbiota in obesity and related comorbidities in children and adolescents: the role of biotics in treatment.
Minerva Pediatr (Torino)
; 74(6): 632-649, 2022 Dec.
Article
em En
| MEDLINE
| ID: mdl-35708037
ABSTRACT
INTRODUCTION:
Obesity is a complex pathology, globally spread, with a multifactorial pathogenesis, strictly linked with lifestyle, hormones, genetic and epigenetic factors. Evidence supports that obesity, and its comorbidities, are related to changes in gut microbiota, partially responsible of the modulation of energy metabolism. EVIDENCE ACQUISITION Pediatric obesity has been associated with lower bacterial diversity and differences in composition of the gut microbiota, also varying according to the metabolic status of obese subjects. Indeed, differences in distributions and activity of microorganisms in the gut of metabolically healthy and unhealthy obese children have been highlighted. EVIDENCESYNTHESIS:
Based on human studies, this review aims to discuss gut microbiota alterations in obese children and adolescents and its role in obese-related complications. Moreover, the role of biotics (probiotics, prebiotics, synbiotics and -marginally- postbiotics) has been analyzed as modulator of obesity-related dysbiosis.CONCLUSIONS:
As a conclusion, a deeper knowledge about biotic mechanisms of action would be of great interest to implement the clinical care of children and adolescents with obesity and related comorbidities.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Probióticos
/
Simbióticos
/
Obesidade Infantil
/
Microbioma Gastrointestinal
Limite:
Adolescent
/
Child
/
Humans
Idioma:
En
Revista:
Minerva Pediatr (Torino)
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Itália